Rankings
▼
Calendar
MLYS
Mineralys Therapeutics, Inc.
$2B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$3M
EPS (Diluted)
$-0.74
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$1,000
Balance Sheet
Total Assets
$1M
Total Liabilities
$5M
Stockholders' Equity
-$4M
Cash & Equivalents
$1M
← FY 2021
All Quarters
MLYS FY 2020 Earnings — Mineralys Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
